AAD Plenary
Learn the latest updates from AAD leadership at the Annual Business Meeting, followed by insights from our plenary speakers, recognition of award recipients, and a keynote address from our esteemed guest.
Read MoreFeb 29, 2024
Learn the latest updates from AAD leadership at the Annual Business Meeting, followed by insights from our plenary speakers, recognition of award recipients, and a keynote address from our esteemed guest.
Read MoreFeb 29, 2024
The American Academy of Dermatology Career Networking Event is an in-person job fair that coincides with the AAD’s Annual Meeting.
Read MoreFeb 29, 2024
There will be over 300 scientific sessions at AAD 2024. Take a look at some of the psoriasis highlights.
Read MoreFeb 29, 2024
Study findings underscore the existence of disparities in geographic access to neurologic care for MS.
Read MoreFeb 29, 2024
A recent study led by Philip De Jager, MD, PhD, marked a significant milestone in understanding the clinical heterogeneity of MS outcomes.
Read MoreFeb 22, 2024
Do you remember the NSCLC research presented at NACLC? Test your knowledge now and see how you rank!
Read MoreFeb 22, 2024
Do you remember the leukemia and lymphoma research presented at ASH? Test your knowledge now and see how you rank!
Read MoreFeb 20, 2024
A study on the nuanced landscape of psoriasis sheds light on the intricate interplay between patient experiences and physician perspectives.
Read MoreFeb 20, 2024
The ACTRIMS Forum 2024 Kenneth P. Johnson Memorial Lecture, “Pioneering B-Cell Therapies,” will be given by Anne H. Cross, MD.
Read MoreFeb 20, 2024
ACTRIMS Forum 2024 launches with Session 1: “Emerging Concepts in MS,” composed of presentations by Young Investigators selected from submitted abstracts.
Read MoreFeb 20, 2024
Take a little time during ACTRIMS Forum 2024 to explore The Square, a dynamic neighborhood offering more than 50 shops and restaurants as well as local events.
Read MoreFeb 15, 2024
After a colonoscopy, patients with inactive IBD were more likely to present to the ED, be hospitalized, and be prescribed steroids within 30 days.
Read MoreFeb 15, 2024
Patients with psoriasis in special areas report greater HRQOL impairment and symptom severity compared with those without special area involvement.
Read MoreFeb 9, 2024
Patients with psoriasis are known to be at a higher risk of various cardiovascular risk factors.
Read MoreFeb 1, 2024
The following is a summary of “Baseline Data and Measurement Instruments Reported in Observational...
Read MoreJan 30, 2024
Several studies were presented at the 2024 Crohn’s & Colitis Congress, covering the impacts on IBD of malnutrition, dietary supplements, and various diets.
Read MoreJan 30, 2024
A recent study and meta-analysis revealed that inflammatory bowel disease (IBD) is associated with...
Read MoreJan 30, 2024
A study found that preoperative exclusive enteral nutrition (EEN) in patients with Crohn’s...
Read MoreJan 29, 2024
Investigators concluded that AI-powered “vascular healing” analysis in UC pinpointed patients...
Read MoreJan 29, 2024
Patient-reported outcomes on HRQOL in psoriasis are limited and require additional validation to properly assess individuals with the condition.
Read More